NCT05339633View on ClinicalTrials.gov

Study in Healthy Adult Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 29, 2022

Primary Completion Date

August 2, 2022

Study Completion Date

October 31, 2022

Conditions
Mass Balance Recovery
Interventions
DRUG

[14C]-D-0502

Drug: \[14C\]-D-0502 and D-0502

Trial Locations (1)

21201

Site Location, Baltimore

Sponsors
All Listed Sponsors
lead

InventisBio Co., Ltd

INDUSTRY